SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Koerwer John

(Last) (First) (Middle)
460 NORTH GULPH ROAD

(Street)
KING OF PRUSSIA PA 19406

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
10/01/2021
3. Issuer Name and Ticker or Trading Symbol
UGI CORP /PA/ [ UGI ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Information Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
UGI Common Stock 13,518 D
UGI Common Stock 2,434 I By 401(k) Plan
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Options (Right to Buy) (1) 12/29/2026 UGI Common Stock 15,000 46.08 D
Options (Right to Buy) (2) 12/31/2027 UGI Common Stock 14,000 46.95 D
Options (Right to Buy) (3) 12/31/2028 UGI Common Stock 10,900 53.35 D
Options (Right to Buy) (4) 12/31/2029 UGI Common Stock 16,180 45.16 D
Options (Right to Buy) (5) 12/31/2030 UGI Common Stock 15,760 34.96 D
Performance Units (6) 12/31/2021 UGI Common Stock 1,740 0.00 D
Performance Units (7) 12/31/2022 UGI Common Stock 2,000 0.00 D
Performance Units (8) 12/31/2023 UGI Common Stock 4,190 0.00 D
Stock Units (9) (9) UGI Common Stock 2,550 0.00 D
Explanation of Responses:
1. These options were granted on December 30, 2016 and were fully vested on December 30, 2019.
2. These options were granted on January 1, 2018 and were fully vested on January 1, 2021.
3. These options were granted on January 1, 2019 and vest in three equal annual installments beginning January 1, 2020.
4. These options were granted on January 1, 2020 and vest in three equal annual installments beginning January 1, 2021.
5. These options were granted on January 1, 2021 and vest in three equal annual installments beginning January 1, 2022.
6. Effective January 1, 2019, the reporting person was granted performance units under the UGI Corporation 2013 Omnibus Incentive Compensation Plan. Each performance unit represents the right of the reporting person to receive a share of UGI Common Stock if specified performance goals and other conditions are met.
7. Effective January 1, 2020, the reporting person was granted performance units under the UGI Corporation 2013 Omnibus Incentive Compensation Plan. Each performance unit represents the right of the reporting person to receive a share of UGI Common Stock if specified performance goals and other conditions are met.
8. Effective January 1, 2021, the reporting person was granted performance units under the UGI Corporation 2013 Omnibus Incentive Compensation Plan. Each performance unit represents the right of the reporting person to receive a share of UGI Common Stock if specified performance goals and other conditions are met.
9. Effective January 1, 2021, the reporting person was granted stock units with dividend equivalents under the UGI Corporation 2013 Omnibus Incentive Compensation Plan. Each stock unit represents the right of the reporting person to receive a share of UGI Common Stock after three years of employment.
Remarks:
/s/ Joshua T. Samples, Attorney-in-Fact for John Koerwer 10/08/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
POWER OF ATTORNEY


	I, John Koerwer hereby authorize and designate:
-	Monica M. Gaudiosi, Vice President and General Counsel, Secretary
-	Jessica A. Milner, Vice President, Law and Assistant Secretary
-	Pamela A. Meredith, Senior Counsel and Assistant Secretary
-	Joshua T. Samples, Counsel

each of whom may act individually to execute, acknowledge and file in my name
and as my attorney-in-fact a Form ID application to obtain EDGAR filing codes, a
Form 3, Initial Statement of Beneficial Ownership of Securities, Forms 4,
Statements of Changes in Beneficial Ownership, and Forms 5, Annual Statements of
Changes in Beneficial Ownership, or any successor reporting forms with the
United States Securities and Exchange Commission (the "SEC") for the purpose of
complying with Section 16 of the Securities Exchange Act of 1934, as amended
(the "Act") and the rules and regulations thereunder with respect to my position
as an officer of UGI Corporation and its affiliates.  The duration of this
authorization shall be coextensive with my reporting obligations as a present or
former officer of UGI Corporation and its affiliates under Section 16 of the
Act.

September 30, 2021               /s/ John Koerwer
Date                             Name:  John Koerwer